Cytek Biosciences (CTKB) EBITDA Margin (2020 - 2026)
Cytek Biosciences' (CTKB) quarterly EBITDA Margin came in at 41.83% in Q1 2026, down 571.0% YoY from 8.88% in Q1 2025, and down 364.7% on a QoQ basis from 9.0% in Q4 2025.
Cytek Biosciences (CTKB) EBITDA Margin (2020 - 2026) Analysis & Trends
Cytek Biosciences (CTKB) has 7 years of EBITDA Margin data on file, last reported at 41.83% in Q1 2026.
- Quarterly EBITDA Margin fell 571.0% year-over-year to 41.83% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 21.49% (down 892.0% YoY) and the FY2025 annual result came in at 20.04%, down 980.0% from the prior year.
- EBITDA Margin eased to 41.83% in Q1 2026, from 9.0% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 5.2% in Q4 2024 to a low of 41.83% in Q1 2026.
- A 5-year average of 14.31% and a median of 13.38% in 2023 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2023 — EBITDA Margin slumped 2607 bps — and 2024, when it jumped 886 bps.
- Tracing CTKB's EBITDA Margin over 5 years: stood at 0.17% in 2022, then tumbled by 235 bps to 0.24% in 2023, then surged by 2308 bps to 5.2% in 2024, then slumped by 273 bps to 9.0% in 2025, then slumped by 365 bps to 41.83% in 2026.
- The last three EBITDA Margin figures came in at 41.83% (Q1 2026), 9.0% (Q4 2025), and 17.58% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 19.15% |
| 10 | Cytek Biosciences | 605.23 Mn | 531.38 Mn | 28.34 Mn | -23.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -23.68% |
| Mar 31, 2026 | -41.83% |
| Dec 31, 2025 | -9.00% |
| Sep 30, 2025 | -17.58% |
| Jun 30, 2025 | -23.30% |
| Mar 31, 2025 | -36.12% |
| Dec 31, 2024 | 5.20% |
| Sep 30, 2024 | -8.25% |
| Jun 30, 2024 | -18.29% |
| Mar 31, 2024 | -23.93% |
| Dec 31, 2023 | -0.24% |
| Sep 30, 2023 | -13.38% |
| Jun 30, 2023 | -18.37% |
| Mar 31, 2023 | -32.79% |
| Dec 31, 2022 | 0.17% |
| Sep 30, 2022 | 3.36% |
| Jun 30, 2022 | -2.22% |
| Mar 31, 2022 | -6.72% |
| Dec 31, 2021 | 3.39% |
| Sep 30, 2021 | 8.43% |